Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127285251 | 12728525 | 1 | I | 20160505 | 0 | 20160907 | 20160907 | DIR | US-FDA-350015 | FDA-CTU | 56.00 | YR | F | N | 67.50000 | KG | 20160907 | Y | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127285251 | 12728525 | 1 | PS | TIZANIDINE HCL 2MG TABS | TIZANIDINE HYDROCHLORIDE | 1 | Oral | OTHER STRENGTH:;OTHER DOSE:1 TABLET;OTHER FREQUENCY:;OTHER ROUTE: | 55111-0179-15 | 0 | 60 | DF | COATED TABLET | HS | |||||
| 127285251 | 12728525 | 3 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 127285251 | 12728525 | 5 | C | CREATOR | 2 | 0 | |||||||||||||
| 127285251 | 12728525 | 7 | C | MULTI VITAMIN | VITAMINS | 1 | 0 | ||||||||||||
| 127285251 | 12728525 | 9 | C | PEPCID | FAMOTIDINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127285251 | 12728525 | 1 | Pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127285251 | 12728525 | Drug effect variable | |
| 127285251 | 12728525 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127285251 | 12728525 | 1 | 20141104 | 0 |